Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients

30 Sept 2022

Abstract excerpt

Despite recent advances in surgical and multimodal therapies, the overall survival (OS) of advanced colorectal cancer (CRC) patients remains low. Thus, discerning sensitive prognostic biomarkers to give the optimistic treatment for CRC patients is extremely critical. N6-methyladenosine (m6A) and long noncoding RNAs (lncRNAs) play an important role in CRC progression. Nonetheless, few studies have focused on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to RNA modifications and cancer
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36246627
DOI: 10.3389/fgene.2022.947747

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patientsPMID 36246627Read ↗

Identification of an m6A-related lncRNA prognostic signature in colorectal cancer.Semantic proximity Read ↗

Evaluated the Role of N6-Methyladenosine-associated lncRNAs in Prognosis and Immune Microenvironment of Colorectal CancerSemantic proximity Read ↗

The Role of N6-Methyladenosine-associated lncRNAs in Immune Microenvironment and Prognosis of Colorectal CancerSemantic proximity Read ↗

Bioinformatics Construction and Experimental Validation of a novel N6- Methylandenosine(m6A)-related lncRNA signature predicts prognosis and immune microenvironment in colon cancerSemantic proximity Read ↗

N6-methylandenosine-related lncRNAs play a key role in the prognosis and immune microenvironment of colon cancerSemantic proximity Read ↗

Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAsSemantic proximity Read ↗

Identification and Validation of m6A-GPI Signatures as a Novel prognostic Model for Colorectal CancerSemantic proximity Read ↗

N6-methylandenosine-related lncRNAs have the prognostic predictive ability for patients with Endometrial CancerSemantic proximity Read ↗

m6A-related lncRNA-based immune infiltration characteristics and prognostic model in colonic adenocarcinomaSemantic proximity Read ↗

Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and Validation of a Seven m6A-related lncRNAs Signature Predicting Prognosis of Ovarian CancerSemantic proximity Read ↗

Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.